Previously, our group reported the institution of a white callus cell line of Buddleja cordata Kunth that may be a excessive producer of the secondary metabolite, verbascoside (VB, additionally named acteoside), below suspension tradition situations.
Here, we current experimental proof of the sustained capability of that mobile line to develop and produce excessive quantities of VB for five years of steady tradition. Cellular line profiles had been decided on the early (at first) and late phases (on the finish of 5 years of steady subculturing) by analyzing related parameters of tradition development, i.e., particular development charge [µ], doubling time [dt], and development index [GI], in addition to VB manufacturing.
Late-stage cultures exhibited a 61% sooner development charge than early-stage subcultures, and 25 and three% decrease doubling time and development index. The extents of development phases had been discovered to be totally different.
EIF4G1 Antibody |
37544-100ul |
SAB |
100ul |
EUR 302.4 |
EIF4G1 siRNA |
20-abx915213 |
Abbexa |
|
|
|
EIF4G1 siRNA |
20-abx915214 |
Abbexa |
|
|
|
EIF4G1 Antibody |
1-CSB-PA780667 |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF4G1. Recognizes EIF4G1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100 |
EIF4G1 Antibody |
1-CSB-PA243767 |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF4G1. Recognizes EIF4G1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
EIF4G1 Antibody |
1-CSB-PA007568GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF4G1. Recognizes EIF4G1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
EIF4G1 Antibody |
1-CSB-PA007999 |
Cusabio |
|
|
|
Description: A polyclonal antibody against EIF4G1. Recognizes EIF4G1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, IF, ELISA;IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/5000 |
anti-EIF4G1 |
YF-PA23636 |
Abfrontier |
50 ul |
EUR 400.8 |
Description: Mouse polyclonal to EIF4G1 |
anti-EIF4G1 |
YF-PA11524 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to EIF4G1 |
Anti-EIF4G1 Antibody |
A01351-2 |
BosterBio |
100ug/vial |
EUR 400.8 |
EIF4G1 Rabbit pAb |
A0881-100ul |
Abclonal |
100 ul |
EUR 460.8 |
EIF4G1 Rabbit pAb |
A0881-200ul |
Abclonal |
200 ul |
Ask for price |
EIF4G1 Rabbit pAb |
A0881-20ul |
Abclonal |
20 ul |
Ask for price |
EIF4G1 Rabbit pAb |
A0881-50ul |
Abclonal |
50 ul |
EUR 318 |
EIF4G1 Blocking Peptide |
33R-6989 |
Fitzgerald |
100 ug |
EUR 216 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EIF4G1 antibody, catalog no. 70R-4875 |
EIF4G1 Blocking Peptide |
20-abx161839 |
Abbexa |
|
|
|
EIF4G1 (pS1232) Antibody |
20-abx000330 |
Abbexa |
-
EUR 594.00
-
EUR 844.80
-
EUR 427.20
|
|
|
EIF4G1 (pS1148) Antibody |
20-abx121476 |
Abbexa |
-
EUR 376.80
-
EUR 560.40
-
EUR 243.60
|
|
|
EIF4G1 Rabbit pAb |
A7552-100ul |
Abclonal |
100 ul |
EUR 369.6 |
EIF4G1 Rabbit pAb |
A7552-200ul |
Abclonal |
200 ul |
EUR 550.8 |
EIF4G1 Rabbit pAb |
A7552-20ul |
Abclonal |
20 ul |
EUR 219.6 |
EIF4G1 Rabbit pAb |
A7552-50ul |
Abclonal |
50 ul |
EUR 267.6 |
EIF4G1 Blocking Peptide |
DF7614-BP |
Affbiotech |
1mg |
EUR 234 |
EIF4G1 Conjugated Antibody |
C37544 |
SAB |
100ul |
EUR 476.4 |
anti-EIF4G1 (3A10) |
LF-MA10096 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to EIF4G1 |
anti- EIF4G1 antibody |
FNab02724 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against EIF4G1 |
Anti-EIF4G1 antibody |
STJ116294 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: The protein encoded by this gene is a component of the multi-subunit protein complex EIF4F. This complex facilitates the recruitment of mRNA to the ribosome, which is a rate-limiting step during the initiation phase of protein synthesis. The recognition of the mRNA cap and the ATP-dependent unwinding of 5'-terminal secondary structure is catalyzed by factors in this complex. The subunit encoded by this gene is a large scaffolding protein that contains binding sites for other members of the EIF4F complex. A domain at its N-terminus can also interact with the poly(A)-binding protein, which may mediate the circularization of mRNA during translation. Alternative splicing results in multiple transcript variants, some of which are derived from alternative promoter usage. |
Anti-EIF4G1 antibody |
STJ29690 |
St John's Laboratory |
100 µl |
EUR 332.4 |
Description: The protein encoded by this gene is a component of the multi-subunit protein complex EIF4F. This complex facilitates the recruitment of mRNA to the ribosome, which is a rate-limiting step during the initiation phase of protein synthesis. The recognition of the mRNA cap and the ATP-dependent unwinding of 5'-terminal secondary structure is catalyzed by factors in this complex. The subunit encoded by this gene is a large scaffolding protein that contains binding sites for other members of the EIF4F complex. A domain at its N-terminus can also interact with the poly(A)-binding protein, which may mediate the circularization of mRNA during translation. Alternative splicing results in multiple transcript variants, some of which are derived from alternative promoter usage. |
Anti-EIF4G1 antibody |
STJ23520 |
St John's Laboratory |
100 µl |
EUR 471.6 |
Description: The protein encoded by this gene is a component of the multi-subunit protein complex EIF4F. This complex facilitates the recruitment of mRNA to the ribosome, which is a rate-limiting step during the initiation phase of protein synthesis. The recognition of the mRNA cap and the ATP-dependent unwinding of 5'-terminal secondary structure is catalyzed by factors in this complex. The subunit encoded by this gene is a large scaffolding protein that contains binding sites for other members of the EIF4F complex. A domain at its N-terminus can also interact with the poly(A)-binding protein, which may mediate the circularization of mRNA during translation. Alternative splicing results in multiple transcript variants, some of which are derived from alternative promoter usage. |
Anti-EIF4G1 (2A9) |
YF-MA20178 |
Abfrontier |
100 ug |
EUR 435.6 |
Description: Mouse monoclonal to EIF4G1 |
EIF4G1 (pS1148) Blocking Peptide |
20-abx162409 |
Abbexa |
|
|
|
Human EIF4G1 shRNA Plasmid |
20-abx951370 |
Abbexa |
|
|
|
Phospho-eIF4G1 (Ser1147) Antibody |
AF7349 |
Affbiotech |
200ul |
EUR 540 |
Phospho-eIF4G1 (Ser1185) Antibody |
AF7350 |
Affbiotech |
200ul |
EUR 540 |
EIF4G1 (Ab-1232) Antibody |
CSB-PA061737-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
Description: A polyclonal antibody against EIF4G1 (Ab-1232). Recognizes EIF4G1 (Ab-1232) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200 |
Phospho-EIF4G1 (Ser1232) Antibody |
CSB-PA987086-100ul |
Cusabio |
100ul |
EUR 434.4 |
|
Description: A polyclonal antibody against Phospho-EIF4G1 (Ser1232). Recognizes Phospho-EIF4G1 (Ser1232) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:100 |
Mouse EIF4G1 shRNA Plasmid |
20-abx980560 |
Abbexa |
|
|
|
Phospho-eIF4G1 (Ser1147) Antibody |
AF2341 |
Affbiotech |
200ul |
EUR 420 |
Phospho-EIF4G1 (S1148) Antibody |
1-CSB-PA007998 |
Cusabio |
|
|
|
Description: A polyclonal antibody against Phospho-EIF4G1 (S1148). Recognizes Phospho-EIF4G1 (S1148) from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC:1/100-1/300.ELISA:1/40000 |
EIF4G1 (Ab-1232) Antibody |
CSB-PA061737- |
Cusabio |
each |
EUR 402 |
|
Description: A polyclonal antibody against EIF4G1 (Ab-1232). Recognizes EIF4G1 (Ab-1232) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF;WB:1:500-1:1000, IHC:1:50-1:200, IF:1:100-1:200 |
Phospho-EIF4G1 (Ser1232) Antibody |
CSB-PA987086- |
Cusabio |
each |
EUR 402 |
|
Description: A polyclonal antibody against Phospho-EIF4G1 (Ser1232). Recognizes Phospho-EIF4G1 (Ser1232) from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:100 |
Phospho-EIF4G1-S1232 Rabbit pAb |
AP0279-100ul |
Abclonal |
100 ul |
EUR 460.8 |
Phospho-EIF4G1-S1232 Rabbit pAb |
AP0279-200ul |
Abclonal |
200 ul |
EUR 664.8 |
Phospho-EIF4G1-S1232 Rabbit pAb |
AP0279-20ul |
Abclonal |
20 ul |
Ask for price |
Phospho-EIF4G1-S1232 Rabbit pAb |
AP0279-50ul |
Abclonal |
50 ul |
EUR 318 |
Phospho-EIF4G1-S1108 Rabbit pAb |
AP0796-100ul |
Abclonal |
100 ul |
EUR 460.8 |
Phospho-EIF4G1-S1108 Rabbit pAb |
AP0796-200ul |
Abclonal |
200 ul |
EUR 664.8 |
Phospho-EIF4G1-S1108 Rabbit pAb |
AP0796-20ul |
Abclonal |
20 ul |
EUR 219.6 |
Phospho-EIF4G1-S1108 Rabbit pAb |
AP0796-50ul |
Abclonal |
50 ul |
EUR 318 |
EIF4G1 ORF Vector (Human) (pORF) |
ORF018839 |
ABM |
1.0 ug DNA |
EUR 790.8 |
Eif4g1 ORF Vector (Mouse) (pORF) |
ORF043791 |
ABM |
1.0 ug DNA |
EUR 1886.4 |
Eif4g1 ORF Vector (Mouse) (pORF) |
ORF043792 |
ABM |
1.0 ug DNA |
EUR 1886.4 |
Anti-Phospho-EIF4G1-(S1108) antibody |
STJ117894 |
St John's Laboratory |
100 µl |
EUR 471.6 |
Description: The protein encoded by this gene is a component of the multi-subunit protein complex EIF4F. This complex facilitates the recruitment of mRNA to the ribosome, which is a rate-limiting step during the initiation phase of protein synthesis. The recognition of the mRNA cap and the ATP-dependent unwinding of 5'-terminal secondary structure is catalyzed by factors in this complex. The subunit encoded by this gene is a large scaffolding protein that contains binding sites for other members of the EIF4F complex. A domain at its N-terminus can also interact with the poly(A)-binding protein, which may mediate the circularization of mRNA during translation. Alternative splicing results in multiple transcript variants, some of which are derived from alternative promoter usage. |
Anti-Phospho-EIF4G1-(S1232) antibody |
STJ22122 |
St John's Laboratory |
100 µl |
EUR 471.6 |
Description: The protein encoded by this gene is a component of the multi-subunit protein complex EIF4F. This complex facilitates the recruitment of mRNA to the ribosome, which is a rate-limiting step during the initiation phase of protein synthesis. The recognition of the mRNA cap and the ATP-dependent unwinding of 5'-terminal secondary structure is catalyzed by factors in this complex. The subunit encoded by this gene is a large scaffolding protein that contains binding sites for other members of the EIF4F complex. A domain at its N-terminus can also interact with the poly(A)-binding protein, which may mediate the circularization of mRNA during translation. Alternative splicing results in multiple transcript variants, some of which are derived from alternative promoter usage. |
EIF4G1 sgRNA CRISPR Lentivector set (Human) |
K0670901 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
Eif4g1 sgRNA CRISPR Lentivector set (Mouse) |
K4684101 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
EIF4G1 sgRNA CRISPR Lentivector (Human) (Target 1) |
K0670902 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EIF4G1 sgRNA CRISPR Lentivector (Human) (Target 2) |
K0670903 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EIF4G1 sgRNA CRISPR Lentivector (Human) (Target 3) |
K0670904 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif4g1 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
K4684102 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif4g1 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
K4684103 |
ABM |
1.0 ug DNA |
EUR 184.8 |
Eif4g1 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
K4684104 |
ABM |
1.0 ug DNA |
EUR 184.8 |
EIF4G1 Protein Vector (Human) (pPB-C-His) |
PV075353 |
ABM |
500 ng |
EUR 2995.2 |
EIF4G1 Protein Vector (Human) (pPB-N-His) |
PV075354 |
ABM |
500 ng |
EUR 2995.2 |
EIF4G1 Protein Vector (Human) (pPM-C-HA) |
PV075355 |
ABM |
500 ng |
EUR 2995.2 |
EIF4G1 Protein Vector (Human) (pPM-C-His) |
PV075356 |
ABM |
500 ng |
EUR 2995.2 |
EIF4G1 Protein Vector (Mouse) (pPB-C-His) |
PV175162 |
ABM |
500 ng |
EUR 3228 |
EIF4G1 Protein Vector (Mouse) (pPB-N-His) |
PV175163 |
ABM |
500 ng |
EUR 3228 |
EIF4G1 Protein Vector (Mouse) (pPM-C-HA) |
PV175164 |
ABM |
500 ng |
EUR 3228 |
EIF4G1 Protein Vector (Mouse) (pPM-C-His) |
PV175165 |
ABM |
500 ng |
EUR 3228 |
EIF4G1 Protein Vector (Mouse) (pPB-C-His) |
PV175166 |
ABM |
500 ng |
EUR 3214.8 |
EIF4G1 Protein Vector (Mouse) (pPB-N-His) |
PV175167 |
ABM |
500 ng |
EUR 3214.8 |
EIF4G1 Protein Vector (Mouse) (pPM-C-HA) |
PV175168 |
ABM |
500 ng |
EUR 3214.8 |
EIF4G1 Protein Vector (Mouse) (pPM-C-His) |
PV175169 |
ABM |
500 ng |
EUR 3214.8 |
EIF4G1 3'UTR Luciferase Stable Cell Line |
TU006792 |
ABM |
1.0 ml |
EUR 2799.6 |
Eif4g1 3'UTR GFP Stable Cell Line |
TU253905 |
ABM |
1.0 ml |
Ask for price |
Eif4g1 3'UTR Luciferase Stable Cell Line |
TU105738 |
ABM |
1.0 ml |
Ask for price |
EIF4G1 3'UTR GFP Stable Cell Line |
TU056792 |
ABM |
1.0 ml |
EUR 2799.6 |
Eif4g1 3'UTR Luciferase Stable Cell Line |
TU203905 |
ABM |
1.0 ml |
Ask for price |
Eif4g1 3'UTR GFP Stable Cell Line |
TU155738 |
ABM |
1.0 ml |
Ask for price |
Recombinant Human EIF4G1 Protein, GST, E.coli-100ug |
QP5975-ec-100ug |
EnQuireBio |
100ug |
EUR 489.6 |
Recombinant Human EIF4G1 Protein, GST, E.coli-10ug |
QP5975-ec-10ug |
EnQuireBio |
10ug |
EUR 240 |
Recombinant Human EIF4G1 Protein, GST, E.coli-1mg |
QP5975-ec-1mg |
EnQuireBio |
1mg |
EUR 1958.4 |
Recombinant Human EIF4G1 Protein, GST, E.coli-200ug |
QP5975-ec-200ug |
EnQuireBio |
200ug |
EUR 760.8 |
Recombinant Human EIF4G1 Protein, GST, E.coli-500ug |
QP5975-ec-500ug |
EnQuireBio |
500ug |
EUR 1272 |
Recombinant Human EIF4G1 Protein, GST, E.coli-50ug |
QP5975-ec-50ug |
EnQuireBio |
50ug |
EUR 315.6 |
Recombinant Human EIF4G1 Protein, His, Yeast-100ug |
QP5975-ye-100ug |
EnQuireBio |
100ug |
EUR 576 |
Recombinant Human EIF4G1 Protein, His, Yeast-10ug |
QP5975-ye-10ug |
EnQuireBio |
10ug |
EUR 283.2 |
Recombinant Human EIF4G1 Protein, His, Yeast-1mg |
QP5975-ye-1mg |
EnQuireBio |
1mg |
EUR 2262 |
Recombinant Human EIF4G1 Protein, His, Yeast-200ug |
QP5975-ye-200ug |
EnQuireBio |
200ug |
EUR 892.8 |
Recombinant Human EIF4G1 Protein, His, Yeast-500ug |
QP5975-ye-500ug |
EnQuireBio |
500ug |
EUR 1447.2 |
Recombinant Human EIF4G1 Protein, His, Yeast-50ug |
QP5975-ye-50ug |
EnQuireBio |
50ug |
EUR 358.8 |
Rabbit Anti-Rabbit EIF4G1 Polyclonal Antibody, Phospho-Ser1232 |
CPB-851RH |
Creative Diagnostics |
100 ul |
EUR 670.8 |
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) Antibody |
20-abx133143 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) Antibody |
20-abx007344 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) Antibody |
20-abx000885 |
Abbexa |
|
|
|
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) Antibody |
20-abx112379 |
Abbexa |
|
|
|
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) Antibody |
abx330400-100ul |
Abbexa |
100 ul |
EUR 510 |
|
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) Antibody |
20-abx339291 |
Abbexa |
|
|
|
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) Antibody |
20-abx326777 |
Abbexa |
|
|
|
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) Antibody |
abx232724-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) Antibody |
20-abx211163 |
Abbexa |
|
|
|
Human Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) |
1-CSB-EP007568HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Eukaryotic translation initiation factor 4 gamma 1(EIF4G1),partial expressed in E.coli |
Human Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) |
1-CSB-EP007568HUb9 |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Eukaryotic translation initiation factor 4 gamma 1(EIF4G1),partial expressed in E.coli |
Rabbit Anti-Human EIF4G1 (aa 1230-1234) Polyclonal Antibody |
CPB-1225RH |
Creative Diagnostics |
100 ul |
EUR 552 |
Human Eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) |
1-CSB-YP007568HU |
Cusabio |
-
EUR 516.00
-
EUR 280.80
-
EUR 1809.60
-
EUR 770.40
-
EUR 1210.80
-
EUR 349.20
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Eukaryotic translation initiation factor 4 gamma 1(EIF4G1),partial expressed in Yeast |
EIF4G1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
K0670905 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Eif4g1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
K4684105 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
Human Eukaryotic Translation Initiation Factor 4 Gamma 1 (EIF4G1) ELISA Kit |
abx387109-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
EIF4G1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
K0670906 |
ABM |
1.0 ug DNA |
EUR 200.4 |
EIF4G1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
K0670907 |
ABM |
1.0 ug DNA |
EUR 200.4 |
EIF4G1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
K0670908 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif4g1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
K4684106 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif4g1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
K4684107 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eif4g1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
K4684108 |
ABM |
1.0 ug DNA |
EUR 200.4 |
Eukaryotic Translation Initiation Factor 4 Gamma 1 Phospho-Ser1232 (EIF4G1 pS1232) Antibody |
abx332891-100ul |
Abbexa |
100 ul |
EUR 560.4 |
|
Eukaryotic Translation Initiation Factor 4 Gamma 1 Phospho-Ser1148 (EIF4G1 pS1148) Antibody |
20-abx326530 |
Abbexa |
|
|
|
Similar quantities of biomass had been discovered (9.5 g and 9.four g L-1). Verbascoside manufacturing elevated parallel to cell development; maximal yield degree occurred within the mid-exponential part and lasted till the tip of the stationary part (i.e., from the 15th to the 25th day and from the ninth to the 21st day for the early and late phases, correspondingly).
The content material of VB was larger within the late-stage tradition (1.43 ± 0945 g L-1) than within the early-stage tradition (1.21 ± 0.0286 g L-1). Productivity values level out the potential use of B. cordata cell line within the biotechnological manufacturing of VB and for analysis targeted on the biochemistry of secondary metabolism.